medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2014, Number 2

<< Back Next >>

Arch Neurocien 2014; 19 (2)

Comparison of clinical instruments for psychosis in Parkinson’s disease

Rodríguez-Violante M, Cervantes-Arriaga A, de la Fuente-Sandova C, Velázquez-Osuna S, Corona-Vázquez T

Language: Spanish
References: 13
Page: 79-82
PDF size: 100.65 Kb.


ABSTRACT

Psychosis in patients with Parkinson’s disease is common and to date no adequate clinical instruments for evaluation. Objective: to determine the clinical usefulness of two instruments in the assessment of psychosis in Mexican patients with Parkinson’s disease. Methods: we included patients with Parkinson disease and psychosis. Instruments were applied clìncos TUHARS and UM-PDHQ, and were compared with the scale of positive and negative symptoms. Results: both instruments showed low internal consistency although the correlation between total scores of the two instruments was acceptable but not when compared with the PANSS. Conclusions: using the UM-PDHQ TUHARS in conjunction with the diagnostic criteria of NINDS-NIH may be useful as it develops and publishes a scale with adequate clinimetric properties.


REFERENCES

  1. Vand Den Eeden, SK, Tanner, CM, Bernstein, AL, et al. Incidence of Parkinson’s Disease: variation by age, gender, and race/ ethnicity. Am J Epidemiol 2003;157:1015-22.

  2. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007 Jan 30;68(5):384-6.

  3. Poewe W. Psychosis in Parkinson’s disease. Mov Disord 2003; 18(S6):S80-S7.

  4. Papapetropoulos S. Psychotic symptoms in Parkinson’s disease. J Neurol 2005252:752-64.

  5. Saleem I, Hegeman R. A reality test: how well do we understand psychosis in Parkinson’s deisease? J Neuropsychiatry Clin Neurosci 2004;16:1.

  6. Salter B, Anderson K, Weiner W. Psychosis in Parkinson’s disease: case studies. Neurol Clin 2006;24:363-9.

  7. Fénelon G, Mahieux F, Huon R, Ziégler M. Hallucinations in Parkinson’s disease, prevalence, phenomenology and risk factors. Brain 2000; 123:733-45.

  8. Ravina B, Marder K, Fernandez H, Friedman J. Diagnostic Criteria for Psychosis in Parkinson’s disease: report of an NINDS, NMH Work group. Mov Disord 2007; 22(8):1061-8.

  9. Fernández H, Aarsland D, Fénelon G, Friedman J, Marsh L. Scales to assess psychosis in Parkinson’s disease: critique and recommendations. Mov Disord 2008; 23:484-500.

  10. Wada-Isoe K, Ohta K, Imamura K. Assessment of hallucinations in Parkinson’s disease using a novel scale. Ac Neurol Scand 2008; 117:35-40.

  11. Papapetropoulos S, Katzen H, Schrag A, Singer C, Scanlon BK, Nation B, et al. A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson’s disease. BMC Neurol 2008; 8:21.

  12. Virués-Ortega J, Rodríguez-Blázquez C, Micheli F, Carod-Ar tal FJ, Serrano-Dueñas M, Mar tínez-Mar tín P. Cross-cultural evaluation of the modified Parkinson Psychosis Ratiing Scale across disease stages. Mov Disord 2010; 25:1391-8.

  13. Goetz CG. Scales to evaluate psychosis in Parkinson’s disease. Parkinsonism Relat Disord 2009: 15 (Suppl 3):S38-41.




2020     |     www.medigraphic.com